{
    "1": {
        "question": "Lengo kuu la utafiti uliofanyika Uingereza kuhusu chanjo za nyongeza za COVID-19 lilikuwa nini?",
        "options": {
            "A": "Kuamua ufanisi wa dozi ya kwanza ya nyongeza.",
            "B": "Kutambua makundi yaliyo katika hatari kubwa ya kifo cha COVID-19 baada ya dozi ya pili ya nyongeza.",
            "C": "Kulinganisha ufanisi wa chanjo tofauti za COVID-19.",
            "D": "Kutathmini athari za COVID-19 kwa wafanyakazi wa afya.",
            "E": "Kutathmini madhara ya chanjo za nyongeza.",
            "F": "Sijui."
        }
    },
    "2": {
        "question": "Kundi gani lilipatikana kuwa na uwiano wa hatari (HR) wa juu zaidi kwa kifo cha COVID-19 katika utafiti?",
        "options": {
            "A": "Watu wenye pumu.",
            "B": "Watu wenye ulemavu wa kujifunza au Down Syndrome.",
            "C": "Watu wenye ugonjwa sugu wa figo.",
            "D": "Watu wenye kisukari.",
            "E": "Watu wenye shinikizo la damu.",
            "F": "Sijui."
        }
    },
    "3": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye shinikizo la damu la mapafu au fibrosis ulikuwa nini?",
        "options": {
            "A": "1.60",
            "B": "2.29",
            "C": "2.88",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "4": {
        "question": "Umri wa wastani wa watu waliokufa kutokana na COVID-19 katika utafiti ulikuwa nini?",
        "options": {
            "A": "Miaka 67.9",
            "B": "Miaka 82.3",
            "C": "Miaka 84.0",
            "D": "Miaka 50.0",
            "E": "Miaka 90.4",
            "F": "Sijui."
        }
    },
    "5": {
        "question": "Kundi gani la kikabila lilipatikana kuwa na hatari ndogo zaidi ya kifo cha COVID-19 ikilinganishwa na kundi la Waingereza Weupe?",
        "options": {
            "A": "Caribbean Weusi",
            "B": "Kichina",
            "C": "Pakistani",
            "D": "Bangladeshi",
            "E": "Mweupe wa Ireland",
            "F": "Sijui."
        }
    },
    "6": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye saratani ya damu na uboho ulikuwa nini?",
        "options": {
            "A": "1.60",
            "B": "2.29",
            "C": "2.88",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "7": {
        "question": "Hali gani ilihusishwa na hatari kubwa ya kifo cha COVID-19 ikilinganishwa na kifo kisicho cha COVID-19?",
        "options": {
            "A": "Pumu",
            "B": "Ugonjwa wa akili",
            "C": "Cirrhosis ya ini",
            "D": "Arthritis ya baridi yabisi au lupus erythematosus ya mfumo",
            "E": "Shinikizo la damu",
            "F": "Sijui."
        }
    },
    "8": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa Parkinson ulikuwa nini?",
        "options": {
            "A": "1.60",
            "B": "2.74",
            "C": "2.88",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "9": {
        "question": "Asilimia ngapi ya watu katika utafiti walikuwa wanaume?",
        "options": {
            "A": "46.9%",
            "B": "52.2%",
            "C": "48.4%",
            "D": "90.4%",
            "E": "67.9%",
            "F": "Sijui."
        }
    },
    "10": {
        "question": "Hali gani haikutambuliwa kuwa na uwiano wa hatari (HR) zaidi ya 2 kwa kifo cha COVID-19?",
        "options": {
            "A": "Ulemavu wa kujifunza au Down Syndrome",
            "B": "Shinikizo la damu la mapafu au fibrosis",
            "C": "Pumu",
            "D": "Ugonjwa wa neva, multiple sclerosis, myasthenia au ugonjwa wa Huntington",
            "E": "Saratani ya mapafu au mdomo",
            "F": "Sijui."
        }
    },
    "11": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa akili ulikuwa nini?",
        "options": {
            "A": "1.60",
            "B": "2.64",
            "C": "2.88",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "12": {
        "question": "Umri wa wastani wa watu katika utafiti ulikuwa nini?",
        "options": {
            "A": "Miaka 50",
            "B": "Miaka 67.9",
            "C": "Miaka 82.3",
            "D": "Miaka 84.0",
            "E": "Miaka 90.4",
            "F": "Sijui."
        }
    },
    "13": {
        "question": "Hali gani ilihusishwa na uwiano wa hatari (HR) wa 2.57 kwa kifo cha COVID-19?",
        "options": {
            "A": "Saratani ya mapafu au mdomo",
            "B": "Ugonjwa wa akili",
            "C": "Cirrhosis ya ini",
            "D": "Ugonjwa wa Parkinson",
            "E": "Ugonjwa wa neva, multiple sclerosis, myasthenia au ugonjwa wa Huntington",
            "F": "Sijui."
        }
    },
    "14": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye cirrhosis ya ini ulikuwa nini?",
        "options": {
            "A": "1.60",
            "B": "2.64",
            "C": "2.65",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "15": {
        "question": "Kundi gani lilipatikana kuwa na hatari ndogo ya kifo cha COVID-19 ikilinganishwa na kundi la Waingereza Weupe?",
        "options": {
            "A": "Caribbean Weusi",
            "B": "Mhindi",
            "C": "Kundi lingine la kikabila",
            "D": "Yote yaliyo hapo juu",
            "E": "Hakuna kati ya hayo",
            "F": "Sijui."
        }
    },
    "16": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa neva, multiple sclerosis, myasthenia au ugonjwa wa Huntington ulikuwa nini?",
        "options": {
            "A": "1.60",
            "B": "2.29",
            "C": "2.94",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "17": {
        "question": "Asilimia ngapi ya watu wa Waingereza Weupe walikuwa katika utafiti?",
        "options": {
            "A": "46.9%",
            "B": "52.2%",
            "C": "48.4%",
            "D": "90.4%",
            "E": "67.9%",
            "F": "Sijui."
        }
    },
    "18": {
        "question": "Hali gani ilihusishwa na uwiano wa hatari (HR) wa 5.07 kwa kifo cha COVID-19?",
        "options": {
            "A": "Saratani ya mapafu au mdomo",
            "B": "Ugonjwa wa akili",
            "C": "Cirrhosis ya ini",
            "D": "Ulemavu wa kujifunza au Down Syndrome",
            "E": "Ugonjwa wa Parkinson",
            "F": "Sijui."
        }
    },
    "19": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa sugu wa figo (CKD) ulikuwa nini?",
        "options": {
            "A": "1.60",
            "B": "2.29",
            "C": "2.88",
            "D": "3.11",
            "E": "Haijatajwa katika maandishi",
            "F": "Sijui."
        }
    },
    "20": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye pumu katika mfano uliorekebishwa kwa hali zingine za kiafya ulikuwa nini?",
        "options": {
            "A": "0.84",
            "B": "1.22",
            "C": "1.60",
            "D": "2.29",
            "E": "2.88",
            "F": "Sijui."
        }
    },
    "21": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye pumu katika mfano wa ziada ambao haujarekebishwa kwa hali zingine za kiafya ulikuwa nini?",
        "options": {
            "A": "0.84",
            "B": "1.22",
            "C": "1.60",
            "D": "2.29",
            "E": "2.88",
            "F": "Sijui."
        }
    },
    "22": {
        "question": "Asilimia ngapi ya vifo vya COVID-19 vilikuwa vya wanaume?",
        "options": {
            "A": "46.9%",
            "B": "52.2%",
            "C": "48.4%",
            "D": "90.4%",
            "E": "67.9%",
            "F": "Sijui."
        }
    },
    "23": {
        "question": "Uwiano wa hatari (HR) kwa kifo kisicho cha COVID-19 kwa watu waliokuwa na unene uliokithiri ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "2.88",
            "E": "3.11",
            "F": "Sijui."
        }
    },
    "24": {
        "question": "Uwiano wa hatari (HR) kwa kifo kisicho cha COVID-19 kwa watu waliokuwa na uzito mdogo ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "2.45",
            "E": "3.11",
            "F": "Sijui."
        }
    },
    "25": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu waliotangaza wenyewe kuwa na ulemavu ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "Haijatajwa katika maandishi",
            "E": "3.11",
            "F": "Sijui."
        }
    },
    "26": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye cystic fibrosis ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "Haijatajwa katika maandishi",
            "E": "3.11",
            "F": "Sijui."
        }
    },
    "27": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye arthritis ya baridi yabisi au lupus erythematosus ya mfumo (SLE) ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "Haijatajwa katika maandishi",
            "E": "3.11",
            "F": "Sijui."
        }
    },
    "28": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye saratani ya damu au uboho ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "29": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa Parkinson ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.74",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "30": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye saratani ya mapafu au mdomo ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.57",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "31": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa akili ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.64",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "32": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye cirrhosis ya ini ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.65",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "33": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ulemavu wa kujifunza au Down Syndrome ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "34": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye shinikizo la damu la mapafu au fibrosis ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.88",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "35": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa neva, multiple sclerosis, myasthenia au ugonjwa wa Huntington ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.94",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "36": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye saratani ya damu na uboho ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "37": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa Parkinson ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.74",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "38": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye saratani ya mapafu au mdomo ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.57",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "39": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa akili ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.64",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "40": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye cirrhosis ya ini ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.65",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "41": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ulemavu wa kujifunza au Down Syndrome ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "42": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye shinikizo la damu la mapafu au fibrosis ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.88",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "43": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa neva, multiple sclerosis, myasthenia au ugonjwa wa Huntington ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.94",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "44": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye saratani ya damu na uboho ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "45": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa Parkinson ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.74",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "46": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye saratani ya mapafu au mdomo ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.57",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "47": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ugonjwa wa akili ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.64",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "48": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye cirrhosis ya ini ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.65",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "49": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye ulemavu wa kujifunza au Down Syndrome ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.29",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    },
    "50": {
        "question": "Uwiano wa hatari (HR) kwa kifo cha COVID-19 kwa watu wenye shinikizo la damu la mapafu au fibrosis ulikuwa nini?",
        "options": {
            "A": "1.55",
            "B": "1.60",
            "C": "2.88",
            "D": "3.11",
            "E": "5.07",
            "F": "Sijui."
        }
    }
}